Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- tisotumab vedotin
- Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan)
Interactions between your drugs
clarithromycin tisotumab vedotin
Applies to: Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan), tisotumab vedotin
Clarithromycin may increase the blood levels of the active medication in tisotumab vedotin. This may increase the risk and/or severity of side effects such as nausea; vomiting; diarrhea; loss of appetite; tingling, numbness or burning in the hands and feet; muscle weakness; hair loss; eye disorders (dry eyes, inflammation of the cornea, corneal ulcers, blurred vision, vision loss); bleeding; low red and white blood cell counts; and inflammation of the lungs. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
amoxicillin clarithromycin
Applies to: Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan), Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan)
Information for this minor interaction is available on the professional version.
Drug and food interactions
clarithromycin food
Applies to: Voquezna Triple Pak (amoxicillin / clarithromycin / vonoprazan)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Zirabev
Zirabev is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Mvasi
Mvasi is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Paraplatin
Paraplatin is used to treat ovarian cancer and many other types of cancer. Learn about side ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Avzivi
Avzivi (bevacizumab-tnjn) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.